6533b836fe1ef96bd12a1b74

RESEARCH PRODUCT

Additional file 4 of Opportunistic infections in immunosuppressed patients with juvenile idiopathic arthritis: analysis by the Pharmachild Safety Adjudication Committee

Gabriella GiancaneJoost F. SwartElio CastagnolaAndreas H. GrollGerd HorneffHans-iko HuppertzDaniel J. LovellTom WolfsTroels HerlinPavla DolezalovaHelga SannerGordana SusicFlavio SztajnbokDespoina MaritsiTamas ConstantinVeronika VargovaSujata SawhneyMarite RyggSheila K. OliveiraMarco CattaliniFrancesca BovisFrancesca BagnascoAngela PistorioAlberto MartiniNico WulffraatNicolino Ruperto

subject

musculoskeletal diseases3. Good health

description

Additional file 4 Table 2. Concomitant medications administered at the time of “confirmed OI”. Bio: biologic, mtx: methotrexate; ste: systemic steroids; sDMARDs: synthetic disease modifying antirheumatic drugs; *sDMARDs are intendend other than MTX.